semaglutide company Compound Rybelsus is from the class of medicines called GLP WeightWatchers to sell Novo Nordisk's

Suppressing Glucagon: It also reduces the release of glucagon, a hormone that raises blood sugar levels

At high doses, niacin can affect liver enzymes and blood sugar levels

Despite significant improvements in glycemic control with both agents, particularly a 1.3% HbA1c reduction with liraglutide, and modest weight loss, 16S rRNA sequencing of fecal samples showed no significant changes in either alpha or beta diversity of the gut microbiota across groups

The glucagon component appears to drive this effect by promoting hepatic fat oxidation

Oduori OS, Murao N, Shimomura K, Takahashi H, Zhang Q, Dou H, Sakai S, Minami K, Chanclon B, Guida C, Kothegala L, Tol J, Maejima Y, Yokoi N, Minami Y, Miki T, Rorsman P, Seino S

Figure S6